Senior Director, Investor Relations & Corporate Communications

Role Summary

Senior Director, Investor Relations & Corporate Communications, on-site in San Diego, CA. Leads external engagement with the investment community, media, and broader public audiences, shaping the company’s narrative and ensuring transparent, consistent communication of scientific progress, financial performance, and strategic priorities. Reports to the Chief Corporate and Business Development Officer and collaborates with the CEO, CBO, Legal, and other senior stakeholders. Requires a seasoned communicator with deep capital markets expertise and a sophisticated understanding of the biotech landscape.

Responsibilities

• Develop and implement a comprehensive investor relations and corporate communications strategy aligned with Janux’s mission, pipeline milestones, and business objectives.
• Lead the development and management of external communications strategy, ensuring consistent messaging and brand representation across media, investor, and public channels.
• Build and refine Janux’s brand identity and messaging frameworks to resonate with investors, partners, and the broader biotech ecosystem, strengthening the company’s reputation and market positioning.
• Lead investor engagement initiatives including conferences, non-deal roadshows, R&D/Analyst Days, and KOL webinars.
• Drive investor targeting efforts, cultivating relationships with institutional investors, analysts, and banking partners aligned with Janux’s long-term vision.
• Manage the external communications calendar to ensure strategic alignment across investors, media, and public-facing channels.
• Serve as a key spokesperson to the investment community and media, representing Janux with clarity and credibility.
• Oversee the development of investor-facing and public communications, including earnings releases, investor presentations, press releases, website content, and executive briefing materials.
• Support the preparation and delivery of quarterly earnings calls, investor conferences, and other high-profile engagements.
• Ensure consistency and compliance across all external messaging, including SEC filings (10-K, 10-Q, 8-K, S-3), ESG disclosures, and material event communications.
• Monitor investor sentiment, stock performance, analyst coverage, and capital markets trends; synthesize insights to inform internal strategy and messaging.
• Track sell-side models and compare against internal forecasts to anticipate market expectations and proactively shape communications.
• Take ownership of understanding Janux’s competitive landscape and peer group within the biotech sector, and proactively assess and communicate Janux’s position and value proposition to internal stakeholders and leadership.
• Ensure compliance with SEC regulations, Reg FD, and Janux’s disclosure policies.
• Partner with Legal and Finance to ensure transparency, accuracy, and strategic alignment in all public disclosures.
• Support communications around clinical trial results, corporate transactions, and financing activities.
• Other duties as deemed necessary.

Qualifications

• Required: Minimum of 10 years of experience in investor relations and/or corporate communications, ideally within a publicly traded biotech, pharmaceutical, or life sciences company.
• Required: Strong understanding of capital markets, investor behavior, and biotech valuation drivers.
• Required: Familiarity with SEC regulations, disclosure obligations, and IR best practices.
• Required: Established relationships with key investors, analysts, and media in the healthcare/life sciences space.
• Required: Experience with IR and communications platforms and tools.
• Required: Collaborative, proactive, and comfortable working in a fast-paced, science-driven environment.
• Required: Strong ability to influence and partner with cross-functional teams and senior stakeholders.
• Required: High level of integrity and commitment to ethical standards.
• Preferred: MBA, PhD, or MS.

Skills

• Excellent written and verbal communication skills, with the ability to translate complex scientific and business developments into clear, compelling narratives.
• Capital markets acumen and understanding of biotech valuation drivers.
• Familiarity with SEC regulations, disclosure obligations, and IR best practices.
• Established relationships with key investors, analysts, and media in healthcare/life sciences.
• Experience with IR and communications platforms and tools.
• Collaborative, proactive, and comfortable working in a fast-paced, science-driven environment.
• Strong ability to influence and partner with cross-functional teams and senior stakeholders.
• High level of integrity and commitment to ethical standards.

Education

• Bachelor’s degree in Finance, Biology, Communications, or related field
• Preferred: MBA, PhD, or MS